Basilisco, Gerald Wenna .

HRN: 09-36-42  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2026
CEFUROXIME 1.5GM (VIAL)
01/04/2026
01/04/2026
IVT
1.5g
PTOR
Stat CS
Waiting Final Action 
01/04/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/04/2026
01/04/2026
IVT
500mg
PTOR
Stat CS
Waiting Final Action 
01/05/2026
CEFUROXIME 500MG (TAB)
01/05/2026
01/12/2026
PO
500
Bid
Ltcs
Waiting Final Action 
01/05/2026
METRONIDAZOLE 500MG (TAB)
01/05/2026
01/12/2026
PO
500
Tid
Ltcs
Waiting Final Action 
01/05/2026
MUPIROCIN 2%, 15G (TUBE)
01/05/2026
01/05/2026
TOPICAL
1 Squint
2x A Day
Ltcs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: